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Introduction
Administration of two (or more) drugs that produce similar physiological effects can be a powerful way to lower drug dosage requirements while maintaining the intended functional effect (Hendrickx et al., 2008) . Characterization of the effectiveness of drug combinations is often conducted using isobolographic analysis (Foucquier and Guedj, 2015; Loewe, 1953; Tallarida, 2016) . In classic twodrug isobolograms, the doses of the two drugs that separately produce a functional effect of the same magnitude are plotted as axial points on a two-dimensional Cartesian graph. The two points, with coordinates of (x,0) and (0,y), are connected with a line known as the isobole of additivity, that corresponds to additive dose pairs and separates sub-additive (antagonistic) from super-additive (synergistic) dose combinations (Geary, 2013; Loewe, 1953) .
It has been shown that the isobole of additivity is linear when the two drugs exhibit a constant effect ratio, i.e., the concentration-response curves for the two drugs are superimposable by a shift along the abscissa (Geary, 2013; Grabovsky and Tallarida, 2004; Tallarida, 2016) . This, however, is not the case for many ion channel modulators, which often differ in their maximal effects or numbers of interaction sites. In these cases, the isoboles can be curvilinear (Grabovsky and Tallarida, 2004) and may not even be uniquely defined (Geary, 2013; Tallarida, 2006) , making classical isobolographic analysis an unreliable approach to defining synergy.
Here, we have conducted an isobolographic analysis of direct activation and potentiation of the α1β2γ2L GABA A receptor by pairs of GABAergic drugs. We employed GABA and propofol, separately and in combination, to activate receptors. To examine potentiation, we activated receptors with a low concentration of GABA, and potentiated with propofol and the steroid alfaxalone, separately and in combination. We predicted the isoboles using a co-agonist concerted transition model (Forman, 2012; Monod et al., 1965) . In this model, each agonist independently contributes to the energy stabilizing the open-channel state, with no interactions between agonists (Forman, 2012) . The predicted MOL #109595
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The durations of drug applications were typically 20-40 sec, aimed at reaching the peak response without unnecessary further exposure to the drug. Each drug application was followed by a 2-3 min washout in bath solution.
The concerted transition model: data analysis and predicted isobolograms
Functional characterization of receptor activity was conducted in the Monod-Wyman-Changeux (MWC) allosteric model framework (Chang and Weiss, 1999; Forman, 2012; Karlin, 1967; Monod et al., 1965) rather than open probability is used to describe experimental data due to potential errors associated with this approach. The major source of potential error is an underestimated true peak amplitude in response to saturating GABA and propofol due to, for example, fast desensitization.
A current level corresponding to P open est of 1 was determined by activating the receptors with a saturating concentration (1 mM) of GABA in the presence of 50 μM propofol. From this approach, the estimated open probability of α1β2γ2L receptors in the presence of saturating GABA is 0.83 ± 0.03 (mean ± SEM; n = 5 cells), that is in agreement with previous single-channel and whole-cell studies (Hernandez et al., 2017; Keramidas and Harrison, 2010; Lema and Auerbach, 2006; Ruesch et al., 2012; Steinbach and Akk, 2001 (Chang and Weiss, 1999; Ruesch et al., 2012; Ziemba and Forman, 2016) .
Sample traces are shown in Fig. 1 .
In the MWC formalism, the probability of being open is given by the following equation (Chang and Weiss, 1999; Ruesch et al., 2012) : When two agonists (A and B) that do not bind to the same site are present at the same time, the state function of the receptor is:
Inspection of Eqn. 2 indicates that the effect of agonist B on activation by agonist A can be expressed through a new parameter L*:
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The value for L* was directly determined from the response to 5 µM GABA alone, according to Using Eqn. 1, we first calculated the concentrations of GABA or propofol alone that would produce a P open of 0.5. We then calculated the concentrations of propofol necessary to elicit this response when combined with arbitrarily selected GABA concentrations of 2, 5, 10, 15, or 20 μM. In each case, a value for L* was calculated for a specific concentration of GABA, then the concentration of propofol required to produce P open = 0.5 estimated using Eqns. 2 and 3.
Effects of two potentiating drugs were predicted in a similar fashion. We measured the response to 5 µM GABA alone, then calculated the concentrations of alfaxalone and propofol that separately would potentiate the response to GABA to P open = 0.5. We then predicted the concentrations of propofol that when combined with alfaxalone at concentrations of 0.2, 0.5, 1, or 1.5 μM would potentiate the response to 5 µM GABA to a P open of 0.5. These calculations resulted in highly curvilinear isoboles of additivity. To test the predicted isobolograms experimentally, we exposed oocytes to the drugs separately or in combination at the predicted concentrations, as well as to the combination of 1 mM GABA + 50 µM propofol to estimate the response corresponding to P open est = 1.
Results
GABA A receptor activation by GABA, propofol, or combinations of GABA + propofol
Human α1β2γ2L GABA A receptors were expressed in oocytes and exposed to 1-1000 μM GABA or 5-500 μM propofol. The raw current responses were converted to units of open probability. For that, the concentration-response data were normalized to the peak response obtained from the same set of cells in the presence of 1 mM GABA + 50 μM propofol. This drug combination elicits a current response that is >10% larger than the response to 1 mM GABA alone, and that we have assigned a P open est value of 1. Curve-fitting was done on data pooled from at least 5 cells under each condition using Eqn. 1. The gating equilibrium constant for unliganded receptors (L 0 ) was held at 9000 (see We tested the sensitivity of the fitting results to the imposed value of L 0 . The K GABA and K Prop were minimally affected when L 0 varied between 1000 and 50000. An increase in L 0 was associated with a decrease in fitted c, reflecting the larger energetic contribution by the ligand required to offset the This article has not been copyedited and formatted. The final version may differ from this version. Fig. 2B ), the predicted pairs fall on a highly curvilinear plot.
To examine the agreement between the predicted and experimental data, we exposed oocytes expressing α1β2γ2L receptors to the drug mixtures predicted to generate a response with P open of 0.5.
As can be seen in Fig. 2C and Table 1 , the mean responses are indistinguishable from the predicted value of 0.5. Sample current traces are shown in Fig. 2D .
Potentiation of GABA-activated receptors by alfaxalone, propofol, or combinations of alfaxalone + propofol
We next examined potentiation of the α1β2γ2L receptor. The receptors were activated by 5 μM GABA in the presence of alfaxalone, propofol, or combinations of alfaxalone + propofol. The raw current responses were converted to units of open probability as described above. We calculated the value for L* from the response to 5 μM GABA alone as 16.25, and assumed that there are two binding sites for alfaxalone (Bracamontes et al., 2011; Hosie et al., 2006) . Employing Eqns. 2-4, we To verify these predictions, we compared peak amplitudes from oocytes expressing α1β2γ2L
receptors exposed to the test drug mixtures and to the control response (1 mM GABA + 50 μM propofol) with a P open est of 1. As can be seen in Fig. 2C the relative responses are indistinguishable from the predicted ratio of 0.5. Sample current traces are shown in Fig. 3D .
Discussion
In this study, we conducted an isobolographic analysis of the human α1β2γ2L GABA A receptor determining the concentrations of several GABAergic agents that, alone or in combination, produce a
response with an open probability of 0.5. The analysis was conducted in two experimental settings.
We first studied direct activation of the receptor by GABA, propofol, and combinations of GABA +
propofol. In the second setting, we examined potentiation of GABA-activated receptors by the steroid alfaxalone, propofol, and combinations of alfaxalone + propofol.
Deviation from a linear isobole of additivity is often interpreted as super-or sub-additivity of drug interactions (Loewe, 1953; Tallarida, 2016) . We show here that simple addition of stabilization energy in a co-agonist concerted transition model predicts strongly curvilinear isoboles, deep in the region classically assigned to synergistic interactions. The predicted deflection from linearity is confirmed by experimental data. Table 1 and Fig. 4A , or 5 µM GABA in Table 2 or Fig. 4B ). As can be seen for activation by GABA, propofol and combinations, the combinations produce a larger effect than the sum of the effects of GABA and propofol. It is interesting that the same model for activation may result in situations for which the effect of the combination is not significantly different from the sum of the individual effects. This situation arises when the basal level of activity of the receptor is relatively high, as can occur when a combination of drugs is used to potentiate the response to a low concentration of GABA (Fig. 4B ).
Isobolographic analysis is widely used to describe the effects of combinations of GABAergic drugs.
Deviation from a linear isobole of additivity, typically interpreted as synergy, has been observed in modulation of GABA-activated α1β2γ2L receptors by the combination of propofol + flurazepam (Reynolds and Maitra, 1996), enhancement of [ This article has not been copyedited and formatted. The final version may differ from this version. 
